the Evidence-Based Medicine (EBM) and Clinical Practice Guidelines (CPG) framework has produced a narrow, top-down model of care. While this system has undoubtedly improved consistency and documentation, it has also coincided with a healthcare landscape increasingly shaped by corporate priorities, not patient outcomes.

For healthcare providers, recognising this need is central to modern patient care. For patients, engaging in wellness strategies is no longer optional—it is a responsible, science-aligned response to modern life. Protocols can be developed and delivered at every level of care.

To simply wait for disease to declare itself is to miss the entire point of modern longevity and functional medicine. We must now become proactive custodians of biology — identifying early signs of cellular dysfunction, supporting detoxification pathways, and improving the body’s internal communication networks (paracrine, endocrine, and beyond).

Metformin is safe, cheap, already approved for diabetes. It prevents chronic disease and even ageing. Yet it cannot overcome the regulatory barriers to approval for this indication. What does this say about regulatory approval?

The blanked fear around testosterone may no longer be justified…

Emerging therapies, often used in integrative, functional, or boutique clinical settings, are targeting these mechanisms. Therapies that include nutritional and peptide interventions, microbiome modulation, detoxification protocols, precision supplementation, and regenerative strategies are showing remarkable promise. But they remain largely excluded from mainstream care.

Despite this health landscape, governments and public health agencies continue to pour trillions of dollars annually into healthcare - largely into the management of disease, not its prevention or cure…..

A system focused on process gets good processes. A system focused on outcomes gets good outcomes.

No apologies from the mainstream when functional medicine practtiioners were right all along…..

Is a lack of evidence blocking access to Medicinal Cannabis in Australia? Or something else?

….Animal and early human studies suggest NAD+ restoration can improve metabolism, reduce neurodegeneration, and enhance cardiovascular health. Clinical trials are ongoing to explore NAD+ precursors' effects on aging, chronic diseases, and overall healthspan........…

….gut flora is indispensable for our health and survival. Many essential substances, like certain vitamins, can only be produced by these microorganisms. This also explains why some chemicals, deemed harmless to humans because they don’t target our proteins, can still profoundly harm us by disrupting the gut flora. These microorganisms interact with dietary information, signalling our immune and neurological systems in response........…

….Guidelines are typically built on evidence from studies published in peer-reviewed journals, and these studies are overwhelmingly funded by pharmaceutical companies. Since the approval process prioritises interventions that fit the pharmaceutical model—patentable, profitable, and quantifiable—these therapies dominate the body of evidence.......…

….But chronic disease is different. It results from years and even decades of persisting low level cellular stress and dysfunction. By the time the disease emerges the cellular balancing processes, known as homeostasis, are broken.......…

….Many nations are on the brink of demographic collapse. Low birth rates have led to two severe challenges: a growing proportion of over-65s, often retired and on pensions, and a shrinking total population, with deaths dramatically exceeding births......…

…BPC-157 is a fragment of a naturally occurring gastrointestinal peptide with multiple powerful healing mechanisms….. often used for injury recovery, chronic pain and inflammation and to assist with gastrointestinal disorders and the wear and tear of ageing.....…

…5A1MQ causes cells to produce more energy, burn more fat stores to energy, protect DNA, activate tumour suppressing genes and enhance cellular NAD+ levels....…

…Aged cells and tissues  are not bathed in these messages. The absence of these peptide messengers, combined with the inevitable accumulation of errors and damage from a life well lived, cause different patterns of gene expression. Faulty or unbalanced production of the proteome, errors in post ribosome processing with vitamins minerals glycans and lipids, resulting in lower, less functional levels of metabolic and structural proteins...…

… Human chemical engineering has allowed humans to overcome seemingly impossible challenges. Since the industrial revolution it is estimated that over 350,000 ‘de novo chemicals’ have been registered globally. This is a 50 fold increase since 1950, and is projected to triple again by 2050. ...…..

…Throughout my career, I came to see the limitations of the traditional medical model in addressing the chronic disease epidemic that affects so many. We are managing chronic illness, yes, but are we truly helping people thrive? I grew convinced that the healthcare system was missing a vital opportunity….. This reactive model left little room for the proactive strategies that I believed could help many people avoid illness altogether..…